Love Island star urges fans to get a key health check
The NHS also claims that such health examinations save 'thousands of lives every year'
Cara De La Hoyde-Massey has encouraged fans to prioritise an essential health check-up, even if it seems daunting. The former Love Island star, 34, issued the message in a conversation with celebrity stylist Bronagh Meere on The School Runway Podcast.
"Oh, I had a smear this week as well," Cara told her fellow co-host. "...Everyone should get their smears, guys, just a little PSA [public service announcement]. Get your smear, don't be scared, just do it."
Joining the conversation, Bronagh said: "Yeah, 100%. I mean, I get that some people'll get nervous." Cara said there was no need to worry.
She acknowledged it wasn't exactly comfortable. However, she then made light of the situation.
She said, speaking candidly: "Me and the nurse were laughing because I was like, 'Oh, it goes up there a lot easier now.' Obviously, once two [kids] have come out, it just flies up there, you ain't got nothing to worry about."
Cara isn't alone in highlighting the necessity of smear tests. The NHS also frequently stresses that smear tests save 'thousands of lives' per year. The health service routinely invites eligible Brits aged 25 to 64 for cervical screenings every few years.
READ MORE: 'I flew to Ibiza for a night out and it was cheaper than staying in the UK' READ MORE: Common Sunday Dinner herb fights dementia, diabetes, heart disease and eczema
These five-minute examinations require a patient to undress from the waist down and recline on a bed. A nurse will then carefully place a tube-shaped speculum into the vagina and open it to view the cervix, being the neck of the uterus. A soft brush will collect cell samples from the cervix.
Smear tests are particularly key for observing different types of 'human papillomavirus (HPV)', a prevalent collection of viruses that carry the risk of causing cervical alterations.
HPV can spread through multiple ways, including through sexual intercourse, direct skin-to-skin genital contact, and the sharing of sexual toys. While the body eliminates many strains of HPV, some can linger for extended periods.
These high-risk strains can lead to health problems like genital warts or, in more serious cases, cervical cancer. "Cervical screening checks the health of your cervix and helps find any abnormal changes before they can turn into cancer," NHS guidance explains.
"It's not a test for cancer, it's a test to help prevent cancer. Cervical screening checks a sample of cells from your cervix for certain types of human papillomavirus (HPV). These types of HPV can cause abnormal changes to the cells in your cervix and are called 'high-risk' types of HPV.
"If high-risk types of HPV are found during screening, the sample of cells is also checked for abnormal cell changes. If abnormal cells are found, they can be treated so they do not get a chance to turn into cervical cancer."
Cervical screening invitations are typically mailed, allowing appointments to be arranged upon receipt. People aged 25 to 49 receive invitations for screenings every three years, whereas those aged 50 to 64 are invited every five years.
Anyone over 65 is asked only if their recent test was abnormal. "If you missed your last cervical screening, you do not need to wait for a letter to book an appointment," the NHS adds.
Am I at risk of cervical cancer?
The NHS warns that anyone with a cervix could be at risk of cervical cancer if they have experienced 'any kind of sexual contact'. This encompasses:
Vaginal, oral or anal sex
Any skin-to-skin contact with the genital area
Sharing sex toys
It is also relevant in these situations:
You are a trans man with a cervix
You have received the HPV vaccine
You have undergone a partial hysterectomy that did not remove all of your cervix
You have only ever had one sexual partner, or you've had the same partner for a long time
You are lesbian or bisexual
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
32 minutes ago
- Scottish Sun
Over half of Brits feel lonely at least once a month… but are ashamed to admit it, study shows
Gen Z feels lonelier than any generation—yet hides it behind screens and silence daily NOT ALONE Over half of Brits feel lonely at least once a month… but are ashamed to admit it, study shows Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) OVER half of Brits feel lonely at least once a month – but are ashamed to admit it. A poll of 2,000 adults revealed 56 per cent would rarely or never consider talking to someone else about how isolated they felt. Sign up for Scottish Sun newsletter Sign up 2 The research was commissioned by audio brand, Pure Credit: SWNS Reasons for this included not wanting to burden others (37 per cent), not believing anyone else will understand (21 per cent), and not wanting to appear vulnerable (21 per cent). This may be a reflection on the strength of their support networks, as a quarter (24 per cent) described theirs as lacking – and a further 13 per cent didn't have one at all. Instead, those who feel lonely are likely to distract themselves through entertainment, such as watching TV (47 per cent), going on social media (22 per cent), or listening to the radio (19 per cent). The research was commissioned by audio brand, Pure, which is partnering with Marmalade Trust, a Bristol-based charity dedicated to raising awareness of loneliness and helping people build meaningful connections. As part of this partnership and in support of Loneliness Awareness Week, Pure will be donating 150 radios to individuals across the UK who are looking for support through a period of loneliness. Dr Lalitaa [COR], behaviouralist psychologist and expert in emotional wellbeing, commented: 'Loneliness remains a taboo subject, often shrouded in shame and stigma. 'But human connection is a basic psychological need – one that's increasingly difficult to fulfil in today's fast-paced, digital world. 'It's encouraging to see initiatives like this that provide simple, tangible comfort and help people feel part of something again.' Tara Fisher, COO from Marmalade Trust added: "Loneliness is a natural human emotion that we are all likely to experience in our lifetime. 'But there is still a stigma around loneliness, which means a significant portion of the population are reluctant to speak about these feelings to others – either because they don't feel they have anyone to talk to or are worried about doing so.' Despite these feelings of shame around loneliness, nearly eight in 10 (79 per cent) acknowledged it as a common phenomenon among the general population. Women were also found to feel lonelier than men – with only 16 per cent of women saying they never feel lonely, compared to 26 per cent of men. But perceptions about the generations most affected were not entirely accurate – with 19 per cent of all respondents believing the Silent Generation (born 1928-1945) is impacted the most by loneliness. However, Gen Zs (born 1996-2011) specifically reported feeling lonelier than any other age group, with one third feeling this way a few times a week and 11 per cent even experiencing this every single day. This compares to 19 per cent of the whole population dealing with this a few times a week and only six per cent every day. Worries about being judged (25 per cent) and dismissed (21 per cent) were also higher among Gen Zs – as were desires to socialise more (53 per cent) and make more friends (42 per cent). This compares to the 'famously lonely' Silent Generation – four in 10 of whom reported usually only going an hour maximum without speaking to someone else. A fifth of all those asked agreed on one day as the limit for not speaking to another person before feeling lonely – yet 23 per cent go this long, or longer, without talking to anyone regularly. Regionally, Londoners were most likely to report feeling lonely – with 33 per cent of those living in the capital saying they feel lonely at least a few times a week. Nearly four in 10 (39 per cent) of all respondents also claimed to feel lonelier now than they did five years ago, primarily because it's now harder to meet people. Other reasons included changes in personal relationships (23 per cent), financial stress (22 per cent), and lower self-esteem (20 per cent). The top locations people reported feeling lonely were also established as at home alone (59 per cent), in a crowd (27 per cent), and when having a meal by themselves (26 per cent). Perhaps to stave off this lonely feeling, over half (52 per cent) are more likely to listen to the radio when at home alone, according to data. Other than listening to the news and their favourite music, 38 per cent utilise their broadcast boxes for background noise (38 per cent), company (20 per cent), and making the house feel less quiet (19 per cent). A further 16 per cent specified listening to the radio helps them to feel less lonely, with 15 per cent liking to hear the sound of other people's voices, and 13 per cent enjoying being part of the conversation. Stations providing the best company were also identified as pop music (30 per cent), oldies music (24 per cent), and talk radio stations (21 per cent). Hubert Eiter, spokesperson for Pure, which is donating £5 for every Pure radio sold between June 9 – July 9, 2025 in support of Marmalade Trust, said: 'Pure has been active in supporting loneliness charities over many years and we are proud to partner with the Marmalade Trust this year. 'It's great to see that everyday listening can bring a lot of comfort to people, as it has the power to immediately make a room feel livelier and less quiet – we love the fact that radio is able to provide some company for those who feel lonely from time to time.'
STV News
an hour ago
- STV News
Alzheimer's research suffers 'devastating blow' after new drug rejected by NHS
A woman who has Alzheimer's disease has said the progression of research has suffered a 'devastating blow' after a new drug was rejected for use by NHS Scotland. Donanemab delays the onset of dementia and works by targeting a cause of the disease, rather than just treating its symptoms. But the Scottish Medicines Consortium says there isn't enough evidence to prove how well it works. Recently retired Rynagh has lived an enviable life, growing up in Ireland, moving to the US, and attending New York University. Coming to Scotland, she expected to live out the rest of her life in peaceful retirement. Instead, she found out she had dementia. She's now thrown into finding a cure for Alzheimer's – and says the rejection of this drug is a massive blow. 'What would it take to approve a drug for dementia?', she said. 'Because it seems to be a lost in space for people. There aren't annual check-ups or anything like there are with other diseases. So there's no record of decline, which is unusual when you think about how progress is made with other diseases over time. 'Think about polio, leprosy, and cancer. They were known many years ago, but we don't talk about them because of the needs and the cost. 'And I understand that cost is a factor, but the burden on society, even in comparison to those other diseases, is tremendous. Absolutely. And only tremendous. It's not just the individual, it's the community, it's the family. 'It's the cost to the next generation for what they lose out by having to provide that care and not being able to support their own families, immediate families, in the way that they will.' Donanemab works when antibodies are given by infusion into a vein in the arm – they then bind with amyloids in the brain, a protein that builds up in Alzheimer's patients, and leads to cognitive decline. Those antibodies trigger immune cells, which clear the amyloid – and slow down the alzheimer's process. The Scottish Medicines Consortium rejected donanemab for use on the NHS as it said there wasn't 'enough evidence of how well it works.' Meanwhile manufacturer Lilly claims the decision 'does not consider … the clinical efficacy and cost-effectiveness' of the drug. It's left campaigners worried about the future of dementia research. Henry Simmons, chief executive of Alzheimer Scotland, said: 'The process that all drugs go through at present at the both the NHS in Scotland and England is a reasonable process however, we don't think it is a reasonable way to tackle the issues we face in terms of the size and scale of dementia, and what we are calling for is a rethink on that.' There's hope the SMC will reconsider the drug, but in the meantime, Rynagh hopes people living with dementia don't give up – and that awareness of the illness continues to grow. 'Well, when it comes down to it, it is the public', she added. 'And if the public doesn't have the awareness, they won't push. 'You know, like 66% is that about two thirds of people with dementia are women. Women typically are the caregivers, but then they need the care and it becomes this cycle and it is increasing instead of decreasing. 'And also with the population pyramid is kind of changing as well. We know that that the elderly population is getting bigger and that's it's a disaster that you should be able to see. 'It's not that you're seeing one seventh of the iceberg. We're now coming to the point where it's so far above the water, it should be that you can go around us and go through it and disperse it, but are not even talking about it at the level that we need to be talking about it.' Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country
Daily Mail
an hour ago
- Daily Mail
GP issues warning over new Covid symptom amid fears Nimbus variant will sweep the UK this summer
Doctors are urging anyone with a 'razor blade' throat that they could have a new and highly contagious Covid variant. Dubbed 'Nimbus', the strain is descended from the super virulent Omicron, with 13 cases having already been found in the UK, following a surge in cases in China, Singapore and Hong Kong. Whilst experts say Nimbus symptoms are broadly similar to earlier versions of the virus a 'razor blade sore throat' could be a key sign of the new variant. According to Dr Naveed Asif, a GP at The London General Practice, this distinctive symptom is characterised by a sharp, stabbing pain when swallowing, often at the back of the throat. Other symptoms linked to the strain include redness in the back of the mouth and swollen neck glands as well established common Covid symptoms like fever, muscle aches and congestion. 'However, symptoms can vary widely so vigilance is key', Dr Asif told Manchester Evening News. According to the NHS, Covid symptoms include a high temperature, a new continuous cough, a loss or change to sense of smell or taste, shortness of breath and feeling sick. Whilst only 13 British cases of Nimbus have been identified so, these figures likely underestimate how far the variant has spread. This is because the number of Covid tests carried out has massively decreased since the height of pandemic and lockdown. Data from the UK Health Security Agency (UKHSA) shows the number of people testing positive for Covid has hit record levels this year and is already 97 per cent higher than numbers recorded in March. Experts have also warned that the new strain could lead to a surge in Covid cases over the summer and have urged the vulnerable to get vaccinated. Even those who were previously vaccinated or infected could be at risk of the catching the virus as previously built-up immunity fades over time. Professor Lawrence Young, a virologist at Warwick University, put the potential surge in cases down to warmer weather and busier social lives. 'We are very likely to see a spike of infections over the next couple of months, possibly by later this month or in July. But it's difficult to predict the level of this infection wave,' he told The i Paper. 'Population immunity, either from vaccination or previous infection, is waning and, unlike other respiratory viruses such as flu, the Covid virus continues to spread in hot and humid weather,' he said. Lab studies suggest Nimbus can infect human cells more efficiently than previous strains, making it more likely to infect people. However, there is currently no evidence Nimbus is more likely to cause severe illness or death in those it infects compared to previous variants. But infection with the virus can still be deadly for more vulnerable groups. Covid was a factor in the deaths of just over 300 people in England in May, according to the latest official figures. Experts have also said that current Covid vaccines, which have been reformulated to combat Omicron descendants, are expected to remain effective against Nimbus. According to the World Health Organisation, Nimbus, scientifically known as NB.1.8.1, now accounts for 10.7 per cent of Covid infections worldwide, compared to just 2.5 per cent a month prior. Dr Gayatri Amirthalingam, UKHSA's deputy director, said the organisation was keeping a close eye on Nimbus. 'UKHSA is monitoring all available data relating to SARS-CoV-2 variants in the UK and abroad, and we continue to publish our findings in our regular Flu and Covid-19 surveillance reports,' she said. 'NB.1.8.1 has been detected in small numbers in the UK to date, but international data suggests that it is growing as a proportion of all Covid-19 cases.' Currently adults over the age of 75, care home residents, and those aged six months and over who have weakened immune systems are all eligible for a free Covid vaccine across the UK. This includes organ, bone marrow or stem cell transplant patients, people living with HIV, cancer patients undergoing chemotherapy or radiotherapy and those with genetic disorders affecting the immune system. UKHSA data suggests people who had a Covid jab as part of last spring's booster campaign were 45 per cent less likely to need hospital care for the virus in the weeks that followed compared to the unvaccinated. The agency has urged all people eligible for a vaccine to get jabbed to protect themselves from both NB.1.8.1 and Covid in general.
